Course Provider
Learning Objectives
Participants will review the current treatment options for patients with newly diagnosed chronic phase-chronic myeloid leukemia.
Participants will identify the challenges associated with the selection of optimal first-line therapy.
Participants will discuss the role of generic drugs and other cost-effective strategies for the management of chronic phase-chronic myeloid leukemia based on treatment goals.